CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

被引：3
|
作者：
Ko, Ji Su [1 ,2 ]
Lee, Jeong Hyun [1 ,2 ,4 ,5 ]
Yoon, Dok Hyun [3 ]
Suh, Chong Hyun [1 ,2 ]
Chung, Sae Rom [1 ,2 ]
Choi, Young Jun [1 ,2 ]
Baek, Jung Hwan [1 ,2 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[5] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
来源：
KOREAN JOURNAL OF RADIOLOGY | 2024年 / 25卷 / 04期
关键词：
Acute lymphoblastic leukemia; Adoptive immunotherapy; Chimeric antigen receptor (CAR) T cells; CAR-T cell associated side effects; Cytokine-release syndrome; MANAGEMENT;
D O I：
10.3348/kjr.2023.1100
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：399 / 402
页数：4
相关论文
共 50 条
  • [21] Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-cell Therapy: A Retrospective Study Analyzing Risks, Outcomes, and Healthcare Burden
    Patel, Rushin
    Patel, Mrunal
    Laxmidhar, Fehmida
    Lakhatariya, Khushboo
    Patel, Darshil
    Patel, Zalak
    Shaikh, Safia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [22] Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia
    Hong, Fei
    Shi, Ming
    Cao, Jiang
    Wang, Ying
    Gong, Yanqing
    Gao, Hui
    Li, Zhenyu
    Zheng, Junnian
    Zeng, Lingyu
    He, Aili
    Xu, Kailin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (24) : 11063 - 11074
  • [23] Management of chimeric antigen receptor T-cell induced cytokine release syndrome: Current and emerging approaches
    Shin, Yunjung H.
    Tian, Xiaofan
    Park, Jiyeon J.
    Kim, Gee Y.
    Aboujaoude, Emily
    Sturgill, Marc G.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 159 - 174
  • [24] Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies
    Perl, Markus
    Herfeld, Konstantin
    Harrer, Dennis C.
    Hoepting, Matthias
    Schweiger, Marina
    Sterz, Ulrich
    Knoedler, Leonard
    Heimerl, Susanne
    Hansmann, Leo
    Herr, Wolfgang
    Poeck, Hendrik
    Wolff, Daniel
    Edinger, Matthias
    Hart, Christina
    Fante, Matthias A.
    HAEMATOLOGICA, 2024, 109 (09) : 2969 - 2977
  • [25] Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
    Hu, Yongxian
    Sun, Jie
    Wu, Zhao
    Yu, Jian
    Cui, Qu
    Pu, Chengfei
    Liang, Bin
    Luo, Yi
    Shi, Jimin
    Jin, Aiyun
    Xiao, Lei
    Huang, He
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [26] Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
    Yongxian Hu
    Jie Sun
    Zhao Wu
    Jian Yu
    Qu Cui
    Chengfei Pu
    Bin Liang
    Yi Luo
    Jimin Shi
    Aiyun Jin
    Lei Xiao
    He Huang
    Journal of Hematology & Oncology, 9
  • [27] Is Prophylaxis the Only Way Out for Cytokine Release Syndrome Associated With Chimeric Antigen T-cell Therapy?
    Dave, Prashil
    Vela, Elisa Pallares
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [28] Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies
    Xu, Qian-wen
    Xu, Hui
    Xue, Lei
    Wang, Li
    Zhang, Xu-han
    Yao, Wen
    Wan, Xiang
    Tong, Juan
    Liu, Hui-lan
    Liu, Xin
    Zhu, Xiao-yu
    Sun, Zi-min
    Wang, Xing-bing
    TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (06)
  • [29] The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor-T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma
    Cao, Jun-Xia
    Wang, Hui
    Gao, Wei-Jian
    You, Jia
    Wu, Li-Hua
    Wang, Zheng-Xu
    CYTOTHERAPY, 2020, 22 (04) : 214 - 226
  • [30] Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies
    Freyer, Craig W.
    Porter, David L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (05) : 940 - 948
12345